Insider acquisitions

Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.

Reset
Form 4, 4/A, 5 & 5/AAmounts retain the reported currency, when available.

Transaction timeline & trade size

Choose a reporting owner, transaction period, and security. Open any point for the filing.

Purchases in this page8
Other acquisitions42
Reporting owners41
Sales (not included)Not included in this datasetCheck original SEC filings

Sep 15, 2025 – Oct 13, 2025 · Transaction dates · Current page sample

Reported transaction sizes · security units

HEICO CORP · Class A Common Stock · Purchase (code P) · Non-derivative · Not reported

Reported transaction sizes by transaction date.Each point is one transaction for the selected company, security, and acquisition type. Reporting owners, exact quantities, and values are also provided in the table. These are filing amounts, not a stock-price series.6760HEICO CORP · SCHRIESHEIM ALAN (Director) · Purchase · October 10, 2025 · Quantity 672 · Price 243.934 · Reference value 163,923.648 · Not reportedHEICO CORP · HENRIQUES ADOLFO (Director) · Purchase · October 10, 2025 · Quantity 676 · Price 243.934 · Reference value 164,899.384 · Not reportedSep 15, 2025Oct 13, 2025No reported values to plot for this selection.

Swipe the chart to see the full date range. Exact records are available in the table below.

2 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

50 dated transactions in this page sample · 41 reporting owners.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition typeQuantityPriceReference valueCurrency
Oct 12, 2025CACI INTERNATIONAL INC /DE/CACI Common StockMORRISON SCOTT C (Director)Exercise / conversion83Not reportedNot reportedNot reported
Oct 10, 2025HEICO CORPClass A Common StockSCHRIESHEIM ALAN (Director)Purchase672243.934163,923.648Not reported
Oct 8, 2025Stoke Therapeutics, Inc.Restricted Stock UnitsSMITH IAN F (Chief Executive Officer · Director)Stock award380,00000Not reported
Oct 8, 2025Stoke Therapeutics, Inc.Stock Option (Right to Buy)SMITH IAN F (Chief Executive Officer · Director)Stock award570,00000Not reported
Oct 10, 2025Victory Capital Holdings, Inc.Common StockRappaport Alan (Director)Stock award1,00465.9866,243.92Not reported
Oct 10, 2025Victory Capital Holdings, Inc.Common StockDEMARTINI RICHARD M (Director)Stock award54965.9836,223.02Not reported
Oct 10, 2025Victory Capital Holdings, Inc.Common StockJackson Mary M. (Director)Stock award43565.9828,701.3Not reported
Oct 10, 2025Victory Capital Holdings, Inc.Common StockHirtler-Garvey Karin (Director)Stock award43565.9828,701.3Not reported
Oct 10, 2025Victory Capital Holdings, Inc.Common StockDavanzo Lawrence (Director)Stock award43565.9828,701.3Not reported
Oct 9, 2025Zenas BioPharma, Inc.Common StockNunn Jason Raleigh (Director)Purchase63,158191,200,002Not reported
Oct 9, 2025Zenas BioPharma, Inc.Common StockGeorge Simeon (10% owner) · SR ONE CAPITAL MANAGEMENT, LLC (10% owner)Purchase63,157191,199,983Not reported
Oct 9, 2025Zenas BioPharma, Inc.Common StockGeorge Simeon (10% owner) · SR ONE CAPITAL MANAGEMENT, LLC (10% owner)Purchase63,158191,200,002Not reported
Oct 13, 2025Kymera Therapeutics, Inc.Common StockGollob Jared (Chief Medical Officer)Exercise / conversion6732.081,399.84Not reported
Oct 13, 2025Kymera Therapeutics, Inc.Common StockGollob Jared (Chief Medical Officer)Exercise / conversion8001.311,048Not reported
Oct 9, 2025Chewy, Inc.Class A common stock, par value $0.01CIE Management IX Ltd (10% owner) · BC Partners Holdings Ltd (10% owner) · Argos Holdings GP LLC (10% owner) · Argos Holdings L.P. (10% owner) · Citrus Intermediate Holdings L.P. (10% owner)Conversion13,280,212Not reportedNot reportedNot reported
Oct 10, 2025AN2 Therapeutics, Inc.Common StockMarks Gilbert Lynn (Director)Stock award10,36700Not reported
Oct 10, 2025AN2 Therapeutics, Inc.Common StockAziz Kabeer (Director)Stock award10,36700Not reported
Oct 10, 2025AN2 Therapeutics, Inc.Common StockMartin Patricia A. (Director)Stock award3,27400Not reported
Oct 11, 2025Ryman Hospitality Properties, Inc.Common StockFIORAVANTI MARK (President & CEO · Director)Exercise / conversion6,96600Not reported
Oct 9, 2025Zenas BioPharma, Inc.Common StockENRIGHT PATRICK G (Director)Purchase11,99020.85249,991.5Not reported
Oct 9, 2025Zenas BioPharma, Inc.Common StockENRIGHT PATRICK G (Director)Purchase105,265192,000,035Not reported
Oct 13, 2025Kymera Therapeutics, Inc.Common StockAlbers Jeffrey W. (Director)Exercise / conversion5,00010.3451,700Not reported
Oct 1, 2025HOULIHAN LOKEY, INC.Class A Common StockMund Ronald Scott (Director)Stock award48300Not reported
Oct 10, 2025FENNEC PHARMACEUTICALS INC.Common SharesRALLIS CHRIS A (Director)Exercise / conversion4,0621.234,996.26Not reported
Sep 26, 2025Main Street Capital CORPCommon StockSHIVE DUNIA A (Director)Other acquisition88.371263.755,633.664Not reported
Sep 15, 2025Main Street Capital CORPCommon StockSHIVE DUNIA A (Director)Other acquisition73.19265.174,769.92264Not reported
Oct 10, 2025HEICO CORPClass A Common StockHENRIQUES ADOLFO (Director)Purchase676243.934164,899.384Not reported
Oct 10, 2025Xos, Inc.Common StockRAPP EDWARD J (Director)Stock award1,88300Not reported
Oct 10, 2025Applied Digital Corp.Common StockCummins Wes (CEO; Chairman · Director · 10% owner)Exercise / conversion200,000Not reportedNot reportedNot reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitQureshi Imran Ahmed (Head of North America)Stock award4.9466337.391,668.933374Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitQureshi Imran Ahmed (Head of North America)Stock award41.0548337.3913,851.478972Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitPullum Anne (Head of Europe)Stock award7.0785337.392,388.215115Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitPullum Anne (Head of Europe)Stock award44.4396337.3914,993.476644Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitKurpis Joseph Stephen (PAO and Controller)Stock award33.393337.3911,266.46427Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitBanas Kristy D (Chief Human Resources Officer)Stock award2.4861337.39838.785279Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitBanas Kristy D (Chief Human Resources Officer)Stock award37.1447337.3912,532.250333Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitKrasner Andrew Jay (Chief Financial Officer)Stock award11.9544337.394,033.295016Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitKrasner Andrew Jay (Chief Financial Officer)Stock award56.8731337.3919,188.415209Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitFurman Matthew (General Counsel)Stock award6.8313337.392,304.812307Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitFurman Matthew (General Counsel)Stock award183.8719337.3962,036.540341Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitGebauer Julie Jarecke (Pres.-Health, Wealth & Career)Stock award11.7246337.393,955.762794Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitGebauer Julie Jarecke (Pres.-Health, Wealth & Career)Stock award156.6178337.3952,841.279542Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitHess Carl Aaron (Chief Executive Officer · Director)Stock award14.9537337.395,045.228843Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitHess Carl Aaron (Chief Executive Officer · Director)Stock award71.0922337.3923,985.797358Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitFaber Alexis (Chief Operating Officer)Stock award4.8346337.391,631.145694Not reported
Oct 9, 2025WILLIS TOWERS WATSON PLCRestricted Share UnitFaber Alexis (Chief Operating Officer)Stock award124.4529337.3941,989.163931Not reported
Oct 13, 2025Roivant Sciences Ltd.Common SharesVenker Eric (President & Immunovant CEO)Exercise / conversion20,72715.85328,522.95Not reported
Oct 9, 2025Roivant Sciences Ltd.Common SharesVenker Eric (President & Immunovant CEO)Exercise / conversion104,94015.851,663,299Not reported
Oct 13, 2025ANGIODYNAMICS INCCommon StockTrowbridge Stephen A (EVP and CFO)Purchase89011.169,932.4Not reported
Oct 13, 2025Salesforce, Inc.Common StockBenioff Marc (Chair and CEO · Director)Exercise / conversion2,250161.5363,375Not reported

Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transaction details

Reporting owners, quantities, prices, and source filings.

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Transacted: CACI INTERNATIONAL INC /DE/CACI · company listingsExercise / conversionCACI Common StockNon-derivative security · Code M83Not reported *Value: Not reportedNot reportedView ↗
Transacted: HEICO CORPHEI · HEI-A · company listingsPurchaseClass A Common StockNon-derivative security · Code P672243.934Value: 163,923.648Not reportedView ↗
Transacted: Stoke Therapeutics, Inc.STOK · company listings
SMITH IAN FChief Executive Officer · Director
Stock awardRestricted Stock UnitsDerivative security · Code A380,0000Value: 0Not reportedView ↗
Transacted: Stoke Therapeutics, Inc.STOK · company listings
SMITH IAN FChief Executive Officer · Director
Stock awardStock Option (Right to Buy)Derivative security · Code A570,0000Value: 0Not reportedView ↗
Transacted: Victory Capital Holdings, Inc.VCTR · company listingsStock awardCommon StockNon-derivative security · Code A1,00465.98 *Value: 66,243.92Not reportedView ↗
Transacted: Victory Capital Holdings, Inc.VCTR · company listingsStock awardCommon StockNon-derivative security · Code A54965.98 *Value: 36,223.02Not reportedView ↗
Transacted: Victory Capital Holdings, Inc.VCTR · company listingsStock awardCommon StockNon-derivative security · Code A43565.98 *Value: 28,701.3Not reportedView ↗
Transacted: Victory Capital Holdings, Inc.VCTR · company listingsStock awardCommon StockNon-derivative security · Code A43565.98 *Value: 28,701.3Not reportedView ↗
Transacted: Victory Capital Holdings, Inc.VCTR · company listingsStock awardCommon StockNon-derivative security · Code A43565.98 *Value: 28,701.3Not reportedView ↗
Transacted: Zenas BioPharma, Inc.ZBIO · company listingsPurchaseCommon StockNon-derivative security · Code P63,15819Value: 1,200,002Not reportedView ↗
Transacted: Zenas BioPharma, Inc.ZBIO · company listings
George Simeon10% owner
Joint filing · amounts unallocated
PurchaseCommon StockNon-derivative security · Code P63,15719Value: 1,199,983Not reportedView ↗
Transacted: Zenas BioPharma, Inc.ZBIO · company listings
George Simeon10% owner
Joint filing · amounts unallocated
PurchaseCommon StockNon-derivative security · Code P63,15819Value: 1,200,002Not reportedView ↗
Transacted: Kymera Therapeutics, Inc.KYMR · company listings
Gollob JaredChief Medical Officer
Exercise / conversionCommon StockNon-derivative security · Code M6732.08Value: 1,399.84Not reportedView ↗
Transacted: Kymera Therapeutics, Inc.KYMR · company listings
Gollob JaredChief Medical Officer
Exercise / conversionCommon StockNon-derivative security · Code M8001.31Value: 1,048Not reportedView ↗
Transacted: Chewy, Inc.CHWY · company listingsJoint filing · amounts unallocatedConversionClass A common stock, par value $0.01Non-derivative security · Code C13,280,212Not reported *Value: Not reportedNot reportedView ↗
Transacted: AN2 Therapeutics, Inc.ANTX · company listingsStock awardCommon StockNon-derivative security · Code A10,3670Value: 0Not reportedView ↗
Transacted: AN2 Therapeutics, Inc.ANTX · company listings
Aziz KabeerDirector
Stock awardCommon StockNon-derivative security · Code A10,3670Value: 0Not reportedView ↗
Transacted: AN2 Therapeutics, Inc.ANTX · company listingsStock awardCommon StockNon-derivative security · Code A3,2740Value: 0Not reportedView ↗
Transacted: Ryman Hospitality Properties, Inc.RHP · company listings
FIORAVANTI MARKPresident & CEO · Director
Exercise / conversionCommon StockNon-derivative security · Code M6,9660Value: 0Not reportedView ↗
Transacted: Zenas BioPharma, Inc.ZBIO · company listingsPurchaseCommon StockNon-derivative security · Code P11,99020.85 *Value: 249,991.5Not reportedView ↗
Transacted: Zenas BioPharma, Inc.ZBIO · company listingsPurchaseCommon StockNon-derivative security · Code P105,26519 *Value: 2,000,035Not reportedView ↗
Transacted: Kymera Therapeutics, Inc.KYMR · company listingsExercise / conversionCommon StockNon-derivative security · Code M5,00010.34Value: 51,700Not reportedView ↗
Transacted: HOULIHAN LOKEY, INC.HLI · company listingsStock awardClass A Common StockNon-derivative security · Code A4830 *Value: 0Not reportedView ↗
Transacted: FENNEC PHARMACEUTICALS INC.FENC · company listingsExercise / conversionCommon SharesNon-derivative security · Code M4,0621.23Value: 4,996.26Not reportedView ↗
Transacted: Main Street Capital CORPMAIN · company listingsOther acquisitionCommon StockNon-derivative security · Code J88.371263.75Value: 5,633.664Not reportedView ↗
Transacted: Main Street Capital CORPMAIN · company listingsOther acquisitionCommon StockNon-derivative security · Code J73.19265.17Value: 4,769.92264Not reportedView ↗
Transacted: HEICO CORPHEI · HEI-A · company listingsPurchaseClass A Common StockNon-derivative security · Code P676243.934Value: 164,899.384Not reportedView ↗
Transacted: Xos, Inc.XOS · company listingsStock awardCommon StockNon-derivative security · Code A1,8830Value: 0Not reportedView ↗
Transacted: Applied Digital Corp.APLD · company listings
Cummins WesCEO; Chairman · Director · 10% owner
Exercise / conversionCommon StockNon-derivative security · Code M200,000Not reported *Value: Not reportedNot reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Qureshi Imran AhmedHead of North America
Stock awardRestricted Share UnitDerivative security · Code A4.9466337.39Value: 1,668.933374Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Qureshi Imran AhmedHead of North America
Stock awardRestricted Share UnitDerivative security · Code A41.0548337.39Value: 13,851.478972Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Pullum AnneHead of Europe
Stock awardRestricted Share UnitDerivative security · Code A7.0785337.39Value: 2,388.215115Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Pullum AnneHead of Europe
Stock awardRestricted Share UnitDerivative security · Code A44.4396337.39Value: 14,993.476644Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Kurpis Joseph StephenPAO and Controller
Stock awardRestricted Share UnitDerivative security · Code A33.393337.39Value: 11,266.46427Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Banas Kristy DChief Human Resources Officer
Stock awardRestricted Share UnitDerivative security · Code A2.4861337.39Value: 838.785279Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Banas Kristy DChief Human Resources Officer
Stock awardRestricted Share UnitDerivative security · Code A37.1447337.39Value: 12,532.250333Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Krasner Andrew JayChief Financial Officer
Stock awardRestricted Share UnitDerivative security · Code A11.9544337.39Value: 4,033.295016Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Krasner Andrew JayChief Financial Officer
Stock awardRestricted Share UnitDerivative security · Code A56.8731337.39Value: 19,188.415209Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Furman MatthewGeneral Counsel
Stock awardRestricted Share UnitDerivative security · Code A6.8313337.39Value: 2,304.812307Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Furman MatthewGeneral Counsel
Stock awardRestricted Share UnitDerivative security · Code A183.8719337.39Value: 62,036.540341Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Gebauer Julie JareckePres.-Health, Wealth & Career
Stock awardRestricted Share UnitDerivative security · Code A11.7246337.39Value: 3,955.762794Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Gebauer Julie JareckePres.-Health, Wealth & Career
Stock awardRestricted Share UnitDerivative security · Code A156.6178337.39Value: 52,841.279542Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Hess Carl AaronChief Executive Officer · Director
Stock awardRestricted Share UnitDerivative security · Code A14.9537337.39Value: 5,045.228843Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Hess Carl AaronChief Executive Officer · Director
Stock awardRestricted Share UnitDerivative security · Code A71.0922337.39Value: 23,985.797358Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Faber AlexisChief Operating Officer
Stock awardRestricted Share UnitDerivative security · Code A4.8346337.39Value: 1,631.145694Not reportedView ↗
Transacted: WILLIS TOWERS WATSON PLCWTW · company listings
Faber AlexisChief Operating Officer
Stock awardRestricted Share UnitDerivative security · Code A124.4529337.39Value: 41,989.163931Not reportedView ↗
Transacted: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M20,72715.85Value: 328,522.95Not reportedView ↗
Transacted: Roivant Sciences Ltd.ROIV · company listings
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon SharesNon-derivative security · Code M104,94015.85Value: 1,663,299Not reportedView ↗
Transacted: ANGIODYNAMICS INCANGO · company listingsPurchaseCommon StockNon-derivative security · Code P89011.16Value: 9,932.4Not reportedView ↗
Transacted: Salesforce, Inc.CRM · company listings
Benioff MarcChair and CEO · Director
Exercise / conversionCommon StockNon-derivative security · Code M2,250161.5Value: 363,375Not reportedView ↗

Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →